 OCALA, Fla., May 03, 2021 GLOBE NEWSWIRE -- AIM ImmunoTech Inc. NYSE American: AIM announces that Thomas K. Equels, CEO of AIM ImmunoTech, participated in a Fireside Chat video interview with Ed Woo, Director of Research Senior Analyst at Ascendiant Capital Markets. 